Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ASP Isotopes (ASPI) EBITDA Margin (2023 - 2025)

ASP Isotopes has reported EBITDA Margin over the past 3 years, most recently at 463.91% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 53982.0% to 463.91% in Q4 2025 year-over-year; TTM through Dec 2025 was 716.16%, a 9733.0% increase, with the full-year FY2025 number at 716.16%, up 9625.0% from a year prior.
  • EBITDA Margin reached 463.91% in Q4 2025 per ASPI's latest filing, down from 247.17% in the prior quarter.
  • The five-year high for EBITDA Margin was 247.17% in Q3 2025, with the low at 6186.52% in Q2 2025.
  • The 3-year median for EBITDA Margin is 799.21% (2024), against an average of 1299.65%.
  • The largest YoY upside for EBITDA Margin was 53982bps in 2025 against a maximum downside of -538731bps in 2025.
  • Tracing ASPI's EBITDA Margin over 3 years: stood at 885.01% in 2023, then decreased by -13bps to 1003.73% in 2024, then skyrocketed by 54bps to 463.91% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 463.91%, 247.17%, and 6186.52% for Q4 2025, Q3 2025, and Q2 2025 respectively.